Shanghai EGT Synbio Group Wins the 24th BSB Innovation Award

In the global pursuit of breakthroughs in life sciences and healthy aging, true competitive advantage is built on rigorous scientific research and technological innovation.

Shanghai EGT Synbio Group Co., Ltd. is proud to announce a major milestone: Dr. Ergo® L-Ergothioneine, our flagship longevity ingredient, has been honored with the Natural Products/Raw Materials/Actives Award at the 24th BSB Innovation Award®. Recognized for its robust scientific evidence and groundbreaking synthetic biology manufacturing technology, this achievement highlights our commitment to advancing next-generation healthy aging solutions.

This marks the highest official recognition from Europe’s most prestigious and rigorous panel of judges. Furthermore, it signifies that China's independently developed, high-purity anti-aging raw materials have officially ascended to the pinnacle of the global premium bio-ingredients market.

Reaching the Pinnacle of Europe: Why the BSB Innovation Award is Hailed as the "Oscars of the Cosmetics Industry"

Established in 2003, the European BSB Innovation Award has built a rich legacy over more than two decades, becoming a premier honor in the global cosmetics, natural raw materials, and cutting-edge application concept sectors.

The BSB evaluation system is renowned for its "independent, objective, and exceptionally rigorous scientific standards." To triumph in such a fierce competition among the world's leading raw materials means that Dr. Ergo® has perfectly passed the highest international standards for technological innovation and clinical efficacy.

The Core Barriers of Disruptive Dominance: How Dr. Ergo® Conquered European Judges

In an anti-aging market crowded with homogenized competition, we have always rejected empty marketing slogans. Winning this crown was made possible by the impregnable technological "moat" supporting Dr. Ergo®:

• Pinnacle Purity & Crystalline Aesthetics: Leveraging breakthrough precision fermentation and synthetic biology engineering, Dr. Ergo® achieves an ultimate purity of up to 99.99%. Furthermore, it pioneeringly adopts a crystalline structure with space group P212121. The tightly packed and staggered molecular arrangement fundamentally solves the technical pain points of moisture absorption and unpleasant odors, realizing a truly odorless and highly stable ingredient.

• A Globally Unrivaled Safety "Passport": Safety is the absolute baseline for premium ingredients. Dr. Ergo® has obtained the prestigious US FDA GRAS (Generally Recognized as Safe) affirmation. Concurrently, it has cleared Canada's NHP (Natural Health Product) certification and passed the European Union’s Novel Food conformity assessment.

• A Solid Foundation of Clinical Evidence: Conceptual additions cannot substitute for real clinical feedback. Supervised by the Japan Association for Clinical Trials (JACTA), we completed a randomized, double-blind, placebo-controlled clinical trial involving 66 subjects. After 8 weeks of continuous administration, subjects exhibited a significant increase in facial radiance, along with highly remarkable clinical improvements in elasticity, pores, wrinkles, and deep-seated pigmentation.

• Intelligent Targeting & Patent Moat: Dr. Ergo® is able to utilize the human body’s dedicated OCTN-1 transporter protein, precisely penetrating cell membranes to act directly within skin cells. Moreover, our raw material not only holds Chinese patents but has also secured highly prestigious European Patent protection (EP4520819), ensuring technical exclusivity in the global supply chain.

Shining in Paris: The World Witnesses a Stellar Moment for Chinese Innovation

Looking back to April in Paris, France, the night sky over in-cosmetics was brilliantly illuminated by the grand BSB Innovation Award ceremony. On this star-studded evening gathering the world's top cosmetics and biotechnology players, China's core scientific research power took center stage.

Shanghai EGT Synbio Group Co., Ltd. made a spectacular impression on this world-class European stage with Dr. Ergo® Ergothioneine. The brilliance of Paris that night belonged not only to the romantic capital of fashion but also to a shining milestone marking China's synthetic biology scaling the peaks of global technology.

Receiving this prestigious international honor is the ultimate tribute from a highly rigorous panel of global experts to our foundational technological barriers. Moving forward, Shanghai EGT Synbio Group Co., Ltd. will remain deeply committed to the intersection of longevity science and synthetic biology, continuously pushing the boundaries of life science with impeccable purity and robust, evidence-based data.